Suture Lid Spring for Lid Closure in Patients With Facial Nerve Palsy
Launched by UNIVERSITY OF ALBERTA · Mar 19, 2025
Trial Information
Current as of May 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help people who have difficulty closing their eyelids due to facial nerve issues, known as facial nerve palsy. When someone can't blink properly, their eyes can become dry and irritated, which can lead to serious vision problems. The researchers are testing a special eyelid spring made from surgical stitches. This new device aims to keep the eyelid closed without the need for frequent lubricating drops or other more invasive methods that can be uncomfortable or affect a person's appearance.
To join the trial, participants need to be adults aged 18 or older who have not seen improvement in their eyelid function for at least six weeks. Those who are not able to have surgery while awake with local anesthesia will not be eligible. If you participate, you can expect a minor procedure to place the eyelid spring, with the hope that it will help protect your eyes and improve your quality of life. It's important to note that while this new spring may reduce some risks associated with existing treatments, it may still need to be replaced over time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults 18 years of age or older with facial nerve transection or paralytic lagophthalmos that has not improved after 6 weeks.
- Exclusion Criteria:
- • Patients unable to tolerate awake eyelid surgery under local anesthetic.
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edmonton, Alberta, Canada
Patients applied
Trial Officials
Edsel Ing, MD PhD FRCSC
Principal Investigator
University of Alberta
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported